Dean Leocadio
Urology · Falmouth, MANPI 1902099948
Payments from drug & device makers
Across 146 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$821
- Boston Scientific$489
- Pfizer$324
- AbbVie$228
- Neotract Inc.$218
- Teleflex LLC$154
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,87489%
- Education$36911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 41 | $821 |
| Boston Scientific | 11 | $489 |
| Pfizer | 21 | $324 |
| AbbVie(2 entities) | 12 | $228 |
| Neotract Inc. | 9 | $218 |
| Teleflex LLC | 5 | $154 |
| Antares Pharma, Inc. | 7 | $137 |
| Bayer | 5 | $123 |
| Axonics, Inc. | 3 | $123 |
| Johnson & Johnson | 7 | $109 |
| 180 Medical, Inc. | 5 | $107 |
| Endo Pharmaceuticals Inc. | 6 | $105 |
| KARL Storz Lithotripsy-america | 1 | $53 |
| Myovant Sciences Inc. | 3 | $44 |
| Dendreon Pharmaceuticals LLC | 2 | $40 |
| Urogen Pharma, Inc. | 1 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Blue Earth Diagnostics | 1 | $21 |
| Palette Life Sciences, Inc. | 1 | $19 |
| Coloplast | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,243 in reported general payments places this provider in the 60th percentile of 327 urology providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 33 | $307 |
Paid to pharmacies, not to this prescriber.
Other urology in Falmouth
- James BleilerFalmouth$12K
- Christopher CutieBoston$3.5M
- Henry MitchesonWatertown$1.6M
- Brian EisnerBoston$1.4M
- Mark PrestonBoston$1.2M
- David StaskinBrighton$807K
- Abraham MorgentalerChestnut Hill$522K
- Alejandro SanchezBoston$349K
- Liam HurleyNorth Andover$319K
- Adam KibelBoston$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.